Page last updated: 2024-10-26

etodolac and Adenocarcinoma, Basal Cell

etodolac has been researched along with Adenocarcinoma, Basal Cell in 3 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Research Excerpts

ExcerptRelevanceReference
" Here, we show that the R-enantiomer of the nonsteroidal antiinflammatory drug etodolac inhibited tumor development and metastasis in the transgenic mouse adenocarcinoma of the prostate (TRAMP) model, by selective induction of apoptosis in the tumor cells."3.73The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. ( Bernasconi, M; Carson, DA; Corr, M; Cottam, HB; James, SY; Kolluri, SK; Leoni, LM; Liu, W; Lu, D; Zhang, XK, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolluri, SK1
Corr, M1
James, SY1
Bernasconi, M1
Lu, D1
Liu, W1
Cottam, HB1
Leoni, LM1
Carson, DA1
Zhang, XK1
Kaihara, T1
Fu, KI1
Sano, Y1
Yamashita, K1
Ochiai, A1
Yoshida, S1
Fujimori, T1
Sugihara, I1
Yoshida, M1
Shigenobu, T1
Takagi, H1
Maruyama, K1
Takeuchi, N1
Toda, M1
Inoue, M1
Nakada, H1

Other Studies

3 other studies available for etodolac and Adenocarcinoma, Basal Cell

ArticleYear
The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Feb-15, Volume: 102, Issue:7

    Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Proliferation; Eto

2005
Depressed-type early invasive colon cancer in a patient treated with cyclooxygenase-2 inhibitor.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:5

    Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Colonic Neoplasms; Colonic Polyps; Cyclooxy

2006
Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
    Cancer research, 2006, Jun-15, Volume: 66, Issue:12

    Topics: Adenocarcinoma; Animals; Cell Growth Processes; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2

2006